FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer. Reply

David Malka; Florence Castan; Thierry Conroy

doi:10.1056/nejmc1900712

FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer. Reply

David Malka
, Florence Castan
, Thierry Conroy

Institut Gustave Roussy
Centre régional de lutte du cancer Val d'Aurelle
Institut de Cancérologie de Lorraine

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	1188-1189
Number of pages	2
Journal	New England Journal of Medicine
Volume	380
Issue number	12
DOIs	https://doi.org/10.1056/nejmc1900712
State	Published - 21 Mar 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1056/nejmc1900712

Cite this

@article{ef102958d4314d0aaf00d9d9c8c3d217,

title = "FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer. Reply",

author = "David Malka and Florence Castan and Thierry Conroy",

year = "2019",

month = mar,

day = "21",

doi = "10.1056/nejmc1900712",

language = "אנגלית",

volume = "380",

pages = "1188--1189",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "12",

}

TY - JOUR

T1 - FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer. Reply

AU - Malka, David

AU - Castan, Florence

AU - Conroy, Thierry

PY - 2019/3/21

Y1 - 2019/3/21

UR - https://www.scopus.com/pages/publications/85063602168

U2 - 10.1056/nejmc1900712

DO - 10.1056/nejmc1900712

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 30893544

AN - SCOPUS:85063602168

SN - 0028-4793

VL - 380

SP - 1188

EP - 1189

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 12

ER -

FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer. Reply

UN SDGs

Access to Document

Other files and links

Cite this